Swiss National Bank
PTCT icon

Swiss National Bank’s PTC Therapeutics PTCT Stock Holding History

Swiss National Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
141,465
-1,400
-1% -$101K 0.01% 950
2026
Q1 		$9.73M Buy
142,865
+1,800
+1% +$127K 0.01% 972
2025
Q4 		$10.7M Buy
141,065
+2,800
+2% +$203K 0.01% 937
2025
Q3 		$8.49M Buy
138,265
+2,700
+2% +$141K ﹤0.01% 1047
2025
Q2 		$6.62M Buy
135,565
+1,000
+0.7% +$47.5K ﹤0.01% 1127
2025
Q1 		$6.86M Sell
134,565
-1,700
-1% -$84.8K ﹤0.01% 1082
2024
Q4 		$6.15M Buy
136,265
+1,400
+1% +$59.9K ﹤0.01% 1196
2024
Q3 		$5M Sell
134,865
-800
-0.6% -$26.8K ﹤0.01% 1324
2024
Q2 		$4.15M Buy
135,665
+2,100
+2% +$68K ﹤0.01% 1385
2024
Q1 		$3.89M Hold
133,565
– – ﹤0.01% 1454
2023
Q4 		$3.68M Sell
133,565
-13,200
-9% -$302K ﹤0.01% 1476
2023
Q3 		$3.29M Buy
146,765
+2,100
+1% +$78.1K ﹤0.01% 1531
2023
Q2 		$5.88M Buy
144,665
+5,100
+4% +$250K ﹤0.01% 1214
2023
Q1 		$6.76M Sell
139,565
-15,900
-10% -$727K ﹤0.01% 1083
2022
Q4 		$5.93M Buy
155,465
+3,200
+2% +$133K ﹤0.01% 1210
2022
Q3 		$7.64M Buy
152,265
+1,000
+0.7% +$49K 0.01% 1027
2022
Q2 		$6.06M Buy
151,265
+800
+0.5% +$28.1K ﹤0.01% 1209
2022
Q1 		$5.61M Buy
150,465
+10,300
+7% +$397K ﹤0.01% 1372
2021
Q4 		$5.58M Hold
140,165
– – ﹤0.01% 1396
2021
Q3 		$5.22M Buy
140,165
+700
+0.5% +$28.8K ﹤0.01% 1431
2021
Q2 		$5.89M Sell
139,465
-800
-0.6% -$34.3K ﹤0.01% 1384
2021
Q1 		$6.64M Buy
140,265
+2,500
+2% +$148K ﹤0.01% 1281
2020
Q4 		$8.41M Buy
137,765
+9,500
+7% +$560K 0.01% 1030
2020
Q3 		$6M Buy
128,265
+4,400
+4% +$217K ﹤0.01% 1062
2020
Q2 		$6.29M Buy
123,865
+16,300
+15% +$801K 0.01% 1018
2020
Q1 		$4.8M Buy
107,565
+6,000
+6% +$302K 0.01% 955
2019
Q4 		$4.88M Buy
101,565
+2,500
+3% +$106K 0.01% 1166
2019
Q3 		$3.35M Buy
99,065
+3,300
+3% +$144K ﹤0.01% 1350
2019
Q2 		$4.31M Buy
95,765
+2,000
+2% +$79K ﹤0.01% 1218
2019
Q1 		$3.53M Buy
93,765
+18,300
+24% +$614K ﹤0.01% 1308
2018
Q4 		$2.59M Buy
75,465
+6,600
+10% +$237K ﹤0.01% 1397
2018
Q3 		$3.24M Buy
68,865
+7,400
+12% +$306K ﹤0.01% 1403
2018
Q2 		$2.07M Sell
61,465
-12,100
-16% -$377K ﹤0.01% 1685
2018
Q1 		$1.99M Buy
73,565
+8,000
+12% +$203K ﹤0.01% 1639
2017
Q4 		$1.09M Hold
65,565
– – ﹤0.01% 2037
2017
Q3 		$1.31M Buy
65,565
+9,000
+16% +$176K ﹤0.01% 1891
2017
Q2 		$1.04M Buy
56,565
+6,500
+13% +$87.6K ﹤0.01% 2028
2017
Q1 		$493K Hold
50,065
– – ﹤0.01% 2380
2016
Q4 		$546K Hold
50,065
– – ﹤0.01% 2354
2016
Q3 		$701K Hold
50,065
– – ﹤0.01% 2185
2016
Q2 		$351K Buy
50,065
+2,900
+6% +$21.3K ﹤0.01% 2487
2016
Q1 		$293K Buy
47,165
+9,500
+25% +$165K ﹤0.01% 2496
2015
Q4 		$1.22M Hold
37,665
– – ﹤0.01% 1680
2015
Q3 		$1.01M Buy
37,665
+4,900
+15% +$210K ﹤0.01% 1779
2015
Q2 		$1.58M Buy
32,765
+9,165
+39% +$535K ﹤0.01% 1477
2015
Q1 		$1.44M Buy
23,600
+500
+2% +$30.5K ﹤0.01% 1524
2014
Q4 		$1.2M Buy
23,100
+3,280
+17% +$144K ﹤0.01% 1627
2014
Q3 		$872K Hold
19,820
– – ﹤0.01% 1743
2014
Q2 		$518K Hold
19,820
– – ﹤0.01% 2149
2014
Q1 		$518K Buy
19,820
+13,820
+230% +$371K ﹤0.01% 2103
2013
Q4 		$102K Buy
+6,000
New +$105K ﹤0.01% 2474

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Swiss National Bank's PTCT Position: Q2 2026 in Review

Swiss National Bank reduced its PTC Therapeutics (PTCT) stake by 0.98% in Q2 2026, selling an estimated $101K and leaving 141,465 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #950.

Swiss National Bank first reported a position in PTCT in Q4 2013 and has held it in 51 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Swiss National Bank held 141,465 shares of PTC Therapeutics worth $11.5M as of Q2 2026.
  • Swiss National Bank sold 1,400 PTC Therapeutics shares in Q2 2026, an estimated $101K.
  • PTC Therapeutics made up 0.01% of Swiss National Bank's portfolio in Q2 2026, its #950 holding.
  • Swiss National Bank first reported a position in PTC Therapeutics in Q4 2013 and has held it in 51 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.